Effective and safe examination of Tsumura-hachimijiogan extract granule(Ethical) for the peripheral arterial disease

Effective and safe examination of Tsumura-hachimijiogan extract granule(Ethical) for the peripheral arterial disease - Hachimijiogan study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017332

Enrollment

Registered

2015-04-30

Start date

2015-04-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peripheral arterial disease(PAD)

Interventions

Tsumura-hatimijiogan extract granule (Ethical)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patient with intermittent claudication and ABI under 0.9

Exclusion criteria

Exclusion criteria: the patients with critical comorbidity (liver disease, kidney disease, heart disease, blood disease, or metabolic disease), patients administered or going to be administered medicine under development, and patients administered or going to be administered other Chinese medicine.

Design outcomes

Primary

Measure	Time frame
Walking Impairment Questionnaire(WIQ) as assessment of claudication severity ABI and SPP as an indication for ischemia	—

Countries

Japan

Contacts

Public ContactKoji Kawago

Tokyo Medical University Hachioji Medical Center Cardiovascular surgery

kkawagoh@yamanashi.ac.jp042-665-5611

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026